Isopogen has an agile team with world-class expertise in the operations, clinical development, and commercialization of cellular therapies, complemented by international corporate strategy and financial acumen

PROFESSOR IAN LAWRANCE – GASTROENTEROLOGIST

MMBS, PhD, Fellow of Royal Australasian College of Physicians

Crohn’s specialist, Ian is a Professor in the School of Medicine and Pharmacology, Faculty of Medicine and Dentistry at the University of Western Australia, and a Gastroenterologist at St John of God Subiaco Hospital. He was Head of the Department of Gastroenterology at Fremantle Hospital from 2004-2007, Director of Endoscopic Services at Kaleeya Hospital from 2004-2007, and currently sits on the numerous pharmaceutical IBD drug advisory committees.

He is a member of the WA Drug Evaluation Panel (WADEP), a member of the Australian and New Zealand IBD consortium (ANZIBDC), a previous board member of the Australian IBD Association (AIBDA), a board member of Crohn’s Colitis Cure (CCC) and co-chair of the IBD Genetics Consortium (IIBDGC).

He is a leading expert in the management of Inflammatory Bowel Disease (IBD). He has over 90 peer-reviewed papers in the field of IBD, including in Nature, Nature Genetics, Lancet, NEJM, and Gastroenterology papers. He is on the editorial board of numerous scientific publications and the Genetics Section Editor for Inflammatory Bowel Diseases.

DR MICHAEL MUSK – LUNG SPECIALIST

MMBS, FRACP, Fellow Royal Australian College of Physicians

Michael is the Respiratory Head of Service Fiona Stanley Hospital and Head of Service Advanced Lung Disease Unit Fiona Stanley Hospital and specializes in all aspects of general respiratory medicine with special interests in Lung Transplantation, Interstitial Lung Disease, Pulmonary Vascular Disease, Surgical management of Emphysema, and Interventional Bronchoscopy.

Michael has been the Principle Investigator of numerous clinical trials in the treatment of Idiopathic Pulmonary Fibrosis, lung transplantation, Bronchiolitis, and Bronchiectasis with a special research interest in the area of understanding the pathogenesis of post lung transplant obliterative bronchiolitis.

Michael is a member of the Transplant Society of Australia and New Zealand, Chair of Lung Advisory Committee, the Thoracic Society of Australia and New Zealand, and International Society of Heart and Lung Transplantation.

DR ASHLEY IRIS – KIDNEY SPECIALIST

MMBS, FRACP, Fellow Royal Australian College of Physicians

Ashley is a Clinical Professor at the University of Western Australia and a Clinical Nephrologist at Fiona Stanley Hospital with an interest in clinical research in dialysis, CKD, transplant, and cardiovascular disease.

Ashley provides inpatient and outpatient services at Fiona Stanley Hospital, St John of God Subiaco Hospital, and St John of God Murdoch Hospitals and visits the Pilbara on a regular basis.